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Abstract 
High blood pressure is prevalent among patients over the age of 60, and poor adherence 
to antihypertensive medications is a major cause of failure to achieve optimal blood pressure 
control. It is estimated that 26-59% of patients over the age of 60 are noncompliant with 
prescribed antihypertensive medications.  A 60-year-old Caucasian female, with newly 
diagnosed hypertension, has been on lisinopril for three weeks for blood pressure control.   
During examination, the patient had complaints of an irritating cough that started shortly after 
starting medication.  Despite adding the lisinopril, her blood pressure remains elevated at 160/98. 
Literature search: Several factors were identified in the literature review as influencing 
adherence to prescribed drug therapy.  The search was conducted in PubMed and Cumulative 
Index to Nursing and Allied Health Literature (CINAHL) and initially included studies published 
in English within the past five years. The search was expanded to a custom range of 2001-2018 
to capture all relevant information related to antihypertensive management. This approach 
resulted in a total of 13 articles. Key words included in the search were: Hypertension, 
medication compliance, medication adherence, side effects, older adult, medication 
nonadherence, cardiovascular medications, and barriers. Managing hypertension in older adults 
can be challenging in clinical practice due to noncompliance with medications.  Providers should 
screen for and address patient-specific barriers to medication adherence and equip patients with 
the tools and information needed for successful antihypertensive therapy and optimal blood 
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Background 
High blood pressure, greater than 150/90, is prevalent in patients 60 years and older, and 
poor adherence to antihypertensive medications is a major cause of failure to achieve optimal 
blood pressure control (Lo, Chau, Woo, Thompson, & Choi, 2016).  Hypertension affects 
approximately 70 million people in the United States, and two-thirds of those are 60 years or 
older (Lo, Chau, Woo, Thompson, & Choi, 2016).  It is estimated that the rate of medication 
adherence is 26-59% in persons >60 years old and nonadherence occurs more often in older 
patients who have more medical conditions and require more medications (MacLaughlin et al., 
2005).  
Because the rate of medication adherence tends to be low in the elderly population, 
achieving guideline-recommended blood pressure levels with the use of blood pressure lowering 
medications in older patients has shown to be difficult (Chowdhury et al., 2013).  Studies suggest 
that many older hypertensive patients are unable to achieve optimal blood pressure control 
because of poor adherence to antihypertensive medications (Lo et al., 2016).   Poor adherence is 
related to illness perception, discomfort caused by side effects, having poor provider 
relationships, and low self-efficacy (Lo et al., 2016).  In addition, it can lead to worsening of 
disease, increased comorbid disease, increased health care costs and death (Chowdhury et al., 
2013).   
There are several factors that have been associated with nonadherence to medication 
regimens, including: the health care team (the absence of a quality relationship between the 
patient and the health care provider, which can lead to less trust, not seeing the primary provider 
when needed, decreased comfort in asking questions, and not feeling involved in the treatment 
decisions); drug therapy prescribed (side effects and complexity of drug regimen); patient’s 
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health beliefs (personal beliefs about diseases and medications); and socioeconomic conditions 
(e.g., poverty, health literacy, low social support) (AlGhuair, Hughes, Simpson, & Guirguis, 
2012).  Understanding patient barriers in adhering to antihypertensive medications will allow 
providers to incorporate more appropriative targeted health education strategies for improved 
patient compliance (Lo et al., 2016)  
Case Report 
A 60-year-old Caucasian female, with newly diagnosed hypertension, has been on 
lisinopril for three weeks for blood pressure control.  Her family history is positive for 
hypertension in both her brother and sister, and for cardiovascular disease in her father.  During 
examination, the patient complained of an irritating cough that started shortly after starting 
lisinopril.  At the time of this visit, she was taking a multivitamin, and 20 milligrams of lisinopril 
daily, and an occasional TUMS for indigestion.  She routinely engages in regular exercise and 
follows a low-sodium diet.  Despite the antihypertensive regimen, her blood pressure remains 
elevated at 160/98.  She has been checking her blood pressures at home, with readings ranging 
from 140-144/80.  Findings from a complete history and physical assessment are unremarkable 
except for a history of tobacco use (smoking one pack per day until 10 years ago), and daily 
caffeine intake.  Laboratory data, including basic metabolic panel and lipid panel, were within 
normal limits.  
The Eighth Joint National Committee (JNC8) published guidelines in 2014 that offer 
recommendations for management of hypertension in differing populations, including: people 
older or younger than age 60 years; people aged >18 year with chronic kidney disease; people 
aged >18 with diabetes; and black and nonblack populations ("JNC 8," 2017).  These evidence-
based guidelines focus on initiating antihypertensive medications at specific blood pressure 
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thresholds to improve health outcomes (James, Oparil, & Carter, 2014).  Clinical guidelines now 
support initiating hypertensive treatment in persons 60 years and older when blood pressures 
exceed 150/90 to reduce the disease burden of myocardial infarction, stroke, renal failure, and 
death (James et al., 2014).  There is also evidence to support the use of angiotensin-converting 
enzyme inhibitors (ACE), angiotensin receptor blockers (ARB), calcium channel blockers 
(CCB), or thiazide-type diuretics in reducing blood pressure in the nonblack hypertensive 
population (James et al., 2014).   
Despite a three-week trial of lisinopril, the case patient’s blood pressure remained 
elevated, and, in addition, she developed an irritating cough.  As many as one-third of people 
who take ACE inhibitors develop a dry, hacking cough, often referred to as an ACE cough 
(Peck, 2001).   Side effects are often a reason why patients discontinue therapy and put 
themselves at risk of developing a cardiac event, such as a heart attack (Peck, 2001). After 
careful review of the patient’s medical history, the ACE inhibitor was discontinued, and the 
patient was started on the ARB losartan 50 milligrams per day.  The patient has been directed to 
return to the clinic for evaluation of the effectiveness of the new medication after four weeks of 
therapy.  At that time, kidney function and electrolyte studies will be completed as well as an 
evaluation of blood pressure.   
In this case, the patient was taking medications as prescribed with the development of 
unwanted side effects which, if not addressed, would likely affect adherence in the future.  Many 
patients face barriers which prevent them from adhering to their treatment plan.  Even with 
access to medical care, older patients need effective provider-patient communication to help 
them better understand their health and medications. 
 




Managing hypertension in older adults can be challenging in clinical practice. To 
understand the current knowledge on barriers to effective treatment, a systematic literature 
search was conducted in PubMed and Cumulative Index to Nursing and Allied Health Literature 
(CINAHL) to find information on hypertensive medication compliance in the older population. 
This search was done by accessing these databases using the University of North Dakota’s 
Harley E. French Library of the Health Sciences.  Key words and search terms were used alone 
and in combination were: hypertension, medication compliance, medication adherence, side 
effects, older adults, medication nonadherence, hypertension guidelines, cardiovascular 
medications, and barriers.  The search strategy used Medical Subject Headings (MeSH).   
The initial search in PubMed was limited to randomized control trials, case reports, 
journal articles, clinical trials and systematic reviews.  The search included only those studies in 
English and with publication dates in the past five years.   This resulted in nine journal articles. 
To capture all data related to antihypertensive management, the publication date was expanded to 
a custom range of 2001-2018, which provided a total of 13 articles. The same search parameters 
were applied in the CINAHL database.  Results were hand-checked for duplicates, and one more 
relevant publication was identified.  Articles were reviewed for content, and additional literature 
was identified by reviewing the references of selected journal articles.   
The literature suggests that the most significant modifiable barrier to achieving optimal 
blood pressure control in the elderly patient is adherence to antihypertensive medication 
(Krousel-Wood, Muntner, Islam, Morisky, & Webber, 2009).  Barriers to antihypertensive 
medication adherence are multifactorial (AlGhuair et al., 2012).   The literature consistently 
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supports the association between nonadherence to antihypertension medication and a) the 
patient’s health care team (quality of the relationship between patient and the health care 
provider), b) medication therapy (side effects and complexity of drug regimen), c) patients’ 
health beliefs (personal beliefs about diseases and medications), and d) socioeconomic factors 
(e.g., poverty, health literacy, low social support).   
Studies suggest that many older hypertensive patients are unable to achieve optimal blood 
pressure control because of poor adherence to antihypertensive medications (Lo et al., 2016).   
Adherence is defined as “the extent to which a person’s behavior corresponds with agreed 
recommendations from a health care provider” (AlGhuair et al., 2012, p. 877).  The Centers for 
Disease Control and Prevention (CDC) estimates that about 65% of older adults have 
hypertension and medication nonadherence is a growing problem among older adults (Al-Ruthia 
et al., 2017).  Nonadherence can lead to increased hospitalizations, decreased therapeutic 
benefits, and increased health care costs (Yap, Thirumoorthy, & Kwan, 2016).  The World 
Health Organization (WHO) estimates that 30-50% of older adults are non-adherent with their 
antihypertensive medication regimen, up to 50% discontinue their antihypertensive treatment 
within the first year, and up to 75% of patient do not achieve target blood pressure (Van der 
Laan, Elders, Boons, Nijpels, & Hugtenburg, 2017).  This data demonstrates the need to target 
the older population in identifying barriers that lead to nonadherence.  
The provider-patient relationship is important in helping older patients navigate the 
physical, psychological, social, economic, and lifestyle changes associated with aging (Krousel-
Wood, Muntner, Islam, Morisky, & Webber, 2009).  The development of a trusting therapeutic 
relationship between a patient and their healthcare provider is essential in achieving positive 
health outcomes (Yap, Thirumoorthy, & Kwan, 2016). Elderly patients often have multiple 
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issues that they need addressed during an office visit, and hypertension management and 
medication adherence assessment may not be a provider priority (Turner et al., 2009).   
Patients’ who do not prioritize discussing hypertension or are poorly informed about 
medication instructions, are more likely to be non-adherent (Turner, Hollenbeak, Weiner, Have, 
& Roberts, 2009).   According to Turner et al (2009), provider-patient interaction barriers were 
commonly reported; 15% of patients had trouble following the provider’s advice about taking the 
medications, 26% stated that they did not feel it was important to talk to their provider about 
their blood pressure, and 16% did not feel their provider listened to them (Turner et al., 2009, p. 
677).  Other healthcare team barriers identified were difficulty in obtaining a refill prescription, 
lack of support from the provider, difficulty in scheduling appointments, quality of 
communication, and patient participation (AlGhuair et al., 2012).        
Studies have indicated that older adults who have a positive relationship with their 
provider, are often more compliant with their medication regimen because of the quality time 
spent effectively assessing and treating concerns (Williams, Haskard, & DiMatteo, 2007).  
Routine medical visits also give providers the opportunity to communicate with their patients 
about their diagnosis and treatment options and tailor the education to the fit the patient’s needs 
(Van der Laan, Elders, Boons, Nijpels, & Hugtenburg, 2017).  Therapy barriers also include the 
unwanted effects of medications, the interference medications make on a daily routine, and the 
complexity of the drug regimen the patient needs to take each day (AlGhuair et al., 2012).  
Elderly patients often have multiple chronic diseases which require several different medications 
and create complex treatment plans that can impact medication adherence (MacLaughlin et al., 
2005).    
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Unpleasant side effects are a significant factor in patients discontinuing their medication 
therapy (Van der Laan et al., 2017).  Adverse drug reactions, can ruin quality of life, disrupt 
sleep, and be bothersome, all of which can lead patients to discontinue the medication and have 
inadequate blood pressure control (Alhawassi, Krass, & Pont, 2015).  When starting patients on 
new medications, it is essential for the provider to follow-up with the patient on a more frequent 
basis and inform the patient of the most common side effects associated with the medication 
(Yap et al., 2016).  This can help ensure the new medication is working effectively and allow 
providers the opportunity to change therapy if side effects develop (Yap et al., 2016).  It is 
imperative that providers complete a medication review at each visit and inquire about any 
difficulties with complying with the medication regimen (Yap et al., 2016).  Suggestions such as 
pill boxes to help organize medications, or the use of reminder notes, can also help the patient 
with medication compliance (Williams, Haskard, & DiMatteo, 2007).  
 Patient awareness and understanding of their health conditions and medications can lead 
to compliance and improved blood pressure control (AlGhuair et al., 2012).  Older patients, that 
have had a cardiovascular event in the past, were found to be more compliant with their 
medication treatment (Brindel et al., 2006).  According to Lo and colleagues, the most 
commonly reported patient-related barrier to compliance is a perception that the medication is 
not beneficial (Lo et al., 2016).  Inadequate education about medications and inability to manage 
complex medication regimens can lead to medication non-adherence (Hsu et al., 2014).   In 
addition, a patient may want to be able to streamline his or her medication dosing to make day to 
day management easier (Hsu et al., 2014).  
Attributing unrelated conditions to hypertension may reduce medication compliance 
(Turner et al., 2009).  Turner et al (2009) surveyed 202 elderly patients and reported that many of 
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these patients were unware of the correlation between stress and blood pressure, or that poor 
hypertension management was related to vascular diseases such as stroke and heart attack 
(Turner, Hollenbeak, Weiner, Have, & Roberts, 2009, p. 678). To achieve optimal blood 
pressure control, education targeted at the older population can help raise awareness of the risks 
associated with uncontrolled hypertension (Chowdhury et al., 2013).  MacLaughlin and 
colleagues report that many providers do not routinely assess the literacy level of their older 
patients even though effective screening tools are available (MacLaughlin et al., 2005). 
Socioeconomic factors associated with aging can affect medication adherence. Many 
elderly face economic hardships, experience the death of a spouse, or have a decreased 
understanding of their health (AlGhuair et al., 2012).  Studies have found that elderly patients 
who live alone often lack social and emotional support needed to understand and take 
medications as directed (Dupre et al., 2017).   Social support has been associated with better 
blood pressure management in older adults with hypertension (Williams et al., 2007). According 
to AlGhurair et al. (2012), elderly patients with partial assistance in medication management 
were 3.6 times more likely to adhere to their medication regime than those that had no support 
(AlGhuair et al., 2012).   
Reducing out-of-pocket costs can lead to better medication adherence (O’Quin, 
Semalulu, & Orom, 2015).  Costs of monthly prescriptions are a common barrier among the 
elderly, especially when they hit the “doughnut-hole”, the gap in coverage between standard 
Medicare Part D drug coverage and catastrophic-coverage threshold (O’Quin et al., 2015).  
According to a study conducted by O’Quin et al (2015), when hitting the “doughnut-hole”, 
patients were more likely to take their medications every other day or share medications with 
friends or family to reduce cost (O’Quin et al., 2015, p. 327).  In a survey of 875 older adults, 
BARRIERS TO ADHERENCE OF ANTIHYPERTENSIVE 12 
 
19% had to cut back on their medication use in the past year due to cost (Wick, 2011).  When the 
cost of medication is high, patients are less likely to take them which can increase to worsening 
disease, hospitalization and death (Wick, 2011). 
To screen for some of these barriers, the provider should have the conversation with the 
patient about their home life.  Ask the patient if they have a caregiver, do they live alone, are 
they able to afford their medication, do they have insurance to cover the medications being 
prescribed, and are they capable of managing their own medications on a day to day basis.  
Addressing these specific questions may highlight patient specific barriers and improve 
outcomes for adherence. In addition, to help ease the burden of cost for the patient, providers 
should eliminate unnecessary medications, request generic medications when available, and 
connect patients to programs that help during times of economic hardship. 
In summary, adherence to medications is affected by several factors including the quality 
of the patient-provider relationship, the prescribed drug regimen, the patient’s personal health 
beliefs, and socioeconomic issues.  The literature supports a patient-centered approach as the 
gold standard for improving adherence (Krousel-Wood et al., 2009).  Providers should work to 
create an open and trusting relationship, and incorporate patient beliefs, preferences, goals and 
barriers and allow patients to be involved in treatment decisions (Zullig & Bosworth, 2017).  
Patient-centered communication can help explore the social barriers and help the older 
population maintain independence and health and increase medication compliance (Williams et 
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Learning Points 
Adherence to blood pressure medications is essential for blood pressure control.  Patients 
benefit from a therapeutic patient-provider relationship to help them understand their health, 
medications, and break down potential barriers that pose risks of nonadherence.  Many studies 
included in the literature review cited common barriers that influence medication adherence in 
older patients.  To address these potential barriers, providers should: 
• Engage patients as partners in their health.  Patient satisfaction with their 
healthcare team can influence their medication adherence (Lo et al., 2016).  A 
therapeutic provider-patient relationship and satisfaction with the health care team 
is essential in promoting patient adherence to antihypertensive medications (Van 
der Laan et al., 2017).   
• Screen for and address side effects of prescribed medications. Adverse drug 
reactions and side effects can lead to noncompliance with the agreed treatment 
plan (Van der Laan et al., 2017).  Educate patients on potential side effects and 
follow up in a few weeks and change medications if side effects develop. 
• Simplify treatment regimens when possible. Having multiple medications and a 
complex medication regimen can lead to poor adherence (Hsu et al., 2014). 
• Educate patients on importance of adhering to their medication regimen. Patient 
awareness and understanding of their condition can lead to better medication 
compliance and improved blood pressure control (AlGhuair et al., 2012).   
• Screen for socioeconomic barriers that prevent patients from adhering to their 
medication regimen and provide information on available resources. By asking 
key questions during an office visit, the provider can gain insight into the patients’ 
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support system at home and their ability to manage and afford medications 
(Williams et al., 2007).  
Numerous factors contribute to medication nonadherence in the older population, but by 
addressing patient specific barriers, providers can equip patients with the tools needed for 
successfully managing antihypertensive therapy and achieving optimal blood pressure control.  
  
BARRIERS TO ADHERENCE OF ANTIHYPERTENSIVE 15 
 
References 
Al-Ruthia, Y. S., Hong, S. H., Graff, C., Kocak, M., Soloman, D., & Nolly, R. (2017). 
Examining the relationship between antihypertensive medication satisfaction and 
adherence in older patients. Research in Social and Administrative Pharmacy, 13(3), 602-
613.   
AlGhuair, S. A., Hughes, C. A., Simpson, S. H., & Guirguis, L. M. (2012).  A systematic review 
of patient self-reported barriers to adherence to antihypertensive medications using the 
World Health Organization Multidimensional Adherence Model. The Journal of Clinical 
Hypertension, 14(12), 877-886. 
Alhawassi, T. M., Krass, I., & Pont, L. G. (2015). Prevalence, prescribing and barriers to 
effective management of hypertension in older populations: a narrative review. Journal of 
Pharmaceutical Policy and Practice, 8(24). 
Brindel, P., Hanon, O., Dartigues, J., Ritchie, K., Lacombe, J., Ducimetiere, P., ... Tzourio, C. 
(2006). Prevalence, awareness, treatment, and control of hypertension in the elderly: the 
three-city study. Journal of Hypertension, 24(1), 51-58. 
Chowdhury, E., Owen, A., Krum, H., Wing, L., Ryan, P., Nelson, M., & Reid, C. (2013). 
Barriers to achieving blood pressure treatment targets in elderly hypertensive individuals. 
Journal of Human Hypertension, 27(9), 545-51. 
Dupre, M. E., Nelson, A., Lynch, S. M., Granger, B. B., Xu, H., Churchill, E., ... Peterson, E. D. 
(2017). Socioeconomic, psychosocial and behavioral characteristics of patients 
hospitalized with cardiovascular disease. American Journal of the Medical Sciences, 
354(6), 565-572. 
BARRIERS TO ADHERENCE OF ANTIHYPERTENSIVE 16 
 
Hsu, C., Lemon, J. M., Wong, E. S., Carson-Cheng, E., Perkins, M., Nordstrom, M. S., ... 
Bryson, C. L. (2014). Factors affecting medication adherence: patient perspectives from 
five veterans’ affairs facilities. BMC Health Services Research, 14(533), 1-9. 
James, P. A., Oparil, S., & Carter, B. L. (2014). 2014 Evidence-based guidelines for the 
management of high blood pressure in adults: Report from the panel members appointed 
to the Eighth Joint National Committee. JAMA, 311(5), 507-520. 
Krousel-Wood, M. A., Muntner, P., Islam, T., Morisky, D. E., & Webber, L. S. (2009). Barriers 
to and determinants of medication adherence in hypertension management: Perspective of 
the cohort study of medication adherence among older adults. Medical Clinics of North 
America, 93(3), 753-769. 
Lo, S. H., Chau, J. P., Woo, J., Thompson, D. R., & Choi, K. (2016). Adherence to 
antihypertensive medication in the older adult with hypertension. Journal of 
Cardiovascular Nursing, 31(4), 296-303. 
MacLaughlin, E. J., Raehl, C. L., Treadway, A. K., Sterling, T. L., Zoller, D. P., & Bond, C. A. 
(2005). Assessing medication adherence in the elderly: which tools to use in clinical 
practice? Drugs and Aging, 33(3), 231-55. 
O’Quin, K., Semalulu, T., & Orom, H. (2015). Elder and caregiver solutions to improve 
medication adherence. Health Education Research, 30(2), 323-335. 
Peck, P. (2001). On an ACE inhibitor? You don’t have to cough up a lung. Retrieved from 
https://www.webmd.com/heart-disease/news/20010816/on-ace-inhibitor-you-dont-have-
to-cough-up-lung#1     
The 2014 JNC 8 and 2017 AHA/ACA guidelines for management of high blood pressure in 
adults. (2017). Retrieved from https://sites.jamanetwork.com/jnc8/ 
BARRIERS TO ADHERENCE OF ANTIHYPERTENSIVE 17 
 
Turner, B. J., Hollenbeak, C., Weiner, M. G., Have, T. T., & Roberts, C. (2009). Barriers to 
adherence and hypertension control in a racially diverse representative sample of elderly 
primary care patients. Pharmacoepidemiology and Drug Safety, 18(8), 672-81. 
Van der Laan, D., Elders, P., Boons, C., Nijpels, G., & Hugtenburg, J. (2017). Factors associated 
with antihypertensive medication non-adherence: a systematic review. Journal of Human 
Hypertension, 31, 687-694. 
Wick, J. Y. (2011). Adherence issues in elderly patients. Retrieved from 
http://www.pharmacytimes.com/publications/issue/2011/january2011/rxfocus-0111 
Williams, S. L., Haskard, K. B., & DiMatteo, M. (2007). The therapeutic effects of the 
physician-older patient relationship: effective communication with vulnerable older 
patients. Clinical Interventions in Aging, 2(3), 453-467. 
Yap, A. F., Thirumoorthy, T., & Kwan, Y. H. (2016). Medication adherence in the elderly. 
Journal of Clinical Gerontology and Geriatrics, 7(2), 64-67. 
Zullig, L. L., & Bosworth, H. (2017). Engaging patients to optimize medication adherence. 
Retrieved from https://catalyst.nejm.org/optimize-patients-medication-adherence/    
 
